Japan Science and Technology Agency Japanese Team Develops Nanowire Technology for Detecting Cancer Biomarkers in Urine Premium Given the high yield of miRNA markers they were able to isolate, the researchers believe the approach could be commercialized for routine cancer testing. Canadian, Japanese Teams Reap $21M for Gene Expression Projects NEW YORK (GenomeWeb News) – Nine teams of Canadian and Japanese scientists will use C$21.8 (US $20.8 million) in new funding to study how gene expression caused by environmental factors can impact human health. IP Roundup: Affymetrix; X-Body; OGT; Singapore's Agency for Science, Technology, and Research; Japan Science and Technology Agency Premium Affymetrix has received US Patent No. 8,372,576, "Miniaturized microparticles." The patent claims a method for forming encoded microparticles. Dolomite Licenses Microdroplet Generation IP NEW YORK (GenomeWeb News) – Microfluidics firm Dolomite today said it has licensed microdroplet generation technology IP from the Japan Science and Technology Agency. Microfluidics Firm Dolomite Licenses IP from Japan Science and Technology Agency Premium Microfluidics firm Dolomite said this week that it has licensed microdroplet generation technology from the Japan Science and Technology Agency. Apr 3, 2012 Canada, Japan Ink Partnership to Study Stem Cell Epigenetics Dec 1, 2010 IP Watch: Recent Patents Related to PCR, Nucleic Acid Amplification, and Sample Prep: Dec 1, 2010 Premium Nov 9, 2010 IP Roundup: Nov 9, 2010 Premium Jan 6, 2010 Mammalian Genomes House Non-Retroviral RNA Virus Sequences, Study Finds Breaking News FDA Revises SARS-CoV-2 Test Emergency Use Authorization Requirements to Account for Variants Geisinger Wins $5M NIH Grant to Develop Point-of-Care Genetic Diagnostic Tool Second Genome, Virginia Commonwealth University Partner on NASH Biomarker Discovery LGC Receives CE Mark for AccuPlex SARS-CoV-2, Flu A/B, RSV Reference Material Kit Esophageal Cancer Testing Firm Lucid Diagnostics Files For IPO Twist Bioscience, DeepCDR Collaborate on Antibody Library Design The Scan Booster for At-Risk The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk. Preprints OK to Mention Again Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications. Hundreds of Millions More to Share The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post. Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.